Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
ICON Public Limited Company
ICLR
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $13.4B
$173.06
▼ -1.14%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$66.57 - $211.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 16.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Attractively priced below sector peer average
Momentum
Hot
+53.3% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ICLR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jun 17, 2026
JUN 23, 2026
Reported EPS of $2.50 vs $2.43 consensus (+2.9% surprise). Revenue of $2.1B vs $2.0B expected (+6.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
2 of 4 beats
Q2 26
+2.9%
Q2 26
+2.0%
Q2 26
-11.9%
Q2 26
-19.5%
Next: Jun 17, 2026
Revenue trend · last 1Q
—
Q1 26
$2.0B
Margins · last 1Q
Profit
5.2%
Wall Street consensus
7 analysts · 43% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
43%
Hold
57%
Sell
0%
Median Price Target
$126.00
▼ -27.2% vs $173.06
Latest: Citi · Jun 25, 2026
5 analysts covering
vs Industry
How ICLR stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.